Couverture de DR. SAL – WEIGHT LOSS DRUG CONTROVERSY - 7 20 24

DR. SAL – WEIGHT LOSS DRUG CONTROVERSY - 7 20 24

DR. SAL – WEIGHT LOSS DRUG CONTROVERSY - 7 20 24

Écouter gratuitement

Voir les détails

À propos de ce contenu audio

 FOR MANY PATIENTS, GLP-1 DRUGS LIKE OZEMPIC & WEGOVY LEAD TO SUBSTANTIAL WEIGHT LOSS BUT SOME SEE MUCH LESS BENEFIT AND RESEARCHERS ARE TRYING TO FIGURE OUT WHY? WE SPEAK WITH OUR FRIEND DR. SALVATORE GIORGIANNI, JR., FOUNDER & VP OF HEALTHY MEN, INC. AND THE SENIOR SCIENCE ADVISER TO THE MENS HEALTH NETWORK.
Aucun commentaire pour le moment